UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047411
Receipt number R000054070
Scientific Title Multicenter study for diagnosing hepatic steatosis using attenuation measurement (ATT); Comparison with PDFF (MRI-determined proton density fat fraction).
Date of disclosure of the study information 2022/04/18
Last modified on 2024/04/08 09:42:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter study for diagnosing hepatic steatosis using attenuation measurement (ATT); Comparison with PDFF (MRI-determined proton density fat fraction).

Acronym

ATT (Attenuation Measurement) study

Scientific Title

Multicenter study for diagnosing hepatic steatosis using attenuation measurement (ATT); Comparison with PDFF (MRI-determined proton density fat fraction).

Scientific Title:Acronym

ATT (Attenuation Measurement) study

Region

Japan


Condition

Condition

Chronic liver disease

Classification by specialty

Hepato-biliary-pancreatic medicine Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of hepatic steatosis by ATT

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We assess the accuracy of ATT in assessing hepatic steatosis compared to PDFF

Key secondary outcomes

We verify whether ATT can diagnose fatty liver (liver fat content 5% or more)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who underwent ATT and PDFF within 3 months
Patients with chronic liver disease including viral hepatitis, NAFLD, autoimmune hepatitis, primary biliary cholangitis, and so on
Patients who can follow instructions such as breath-holding.

Key exclusion criteria

Patients without claustrophobia
Patients without magnetic substance or tattoo
Patients without pacemakers
Patients judged as inappropriate for the study by the study responsibility (share) physician.

Target sample size

750


Research contact person

Name of lead principal investigator

1st name Hidenori
Middle name
Last name Toyoda

Organization

Ogaki Municipal Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

503-8502

Address

4-86 Minaminokawa-cho, Ogaki-shi, Gifu-ken

TEL

+81584813341

Email

hmtoyoda@spice.ocn.ne.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Kumada

Organization

Gifu Kyoritsu University

Division name

Department of Nursing, Faculty of Nursing

Zip code

503-8550

Address

5-50, Kitagata-cho, Ogaki-shi, Gifu-ken

TEL

+81584773512

Homepage URL


Email

takashi.kumada@gmail.com


Sponsor or person

Institute

Ogaki Municipal Hospital

Institute

Department

Personal name



Funding Source

Organization

FUJIFILM Healthcare Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Department of Gastroenterology and Metabology, Ehime University School of Medicine.
Department of Gastroenterology, Suita Municipal hospital
Department of Nursing, Gifu Kyoritsu University
Department of Hepatology and Pancreatology, Aichi Medical University
Department of Advanced Metabolic Hepatology, Osaka University Graduate School of Medicine
Department of Gastroenterology, Kagoshima City Hospital
Department of Medical Division of Gastroenterology, Kurume University
Clinical Research Center, National Hospital Organization Nagasaki Medical Center
Department of Gastroenterology, Sasebo City General Hospital

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization

Ogaki Municipal Hospital

Address

4-86/Minaminokawa, Ogaki, Gifu, Japan, 503-8502

Tel

+81-584-81-3341

Email

clinical-trial@omh.ogaki.gifu.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大垣市民病院消化器内科) Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital
愛媛大学大学院医学系研究科医学専攻消化器・内分泌・代謝内科学 Department of Gastroenterology and Metabology, Ehime University School of Medicine.
市立吹田市民病院 消化器内科 Department of Gastroenterology, Suita Municipal hospital
鹿児島市立病院 消化器内科 Department of Gastroenterology, Kagoshima City Hospital
久留米大学医学部内科学講座 消化器内科部門 Department of Medical Division of Gastroenterology, Kurume University
国立病院機構長崎医療センター 臨床研究センター/肝臓内科 Clinical Research Center, National Hospital Organization Nagasaki Medical Center
佐世保市総合医療センター 消化器内科 Department of Gastroenterology, Sasebo City General Hospital


Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 18 Day


Related information

URL releasing protocol

https://pubmed.ncbi.nlm.nih.gov/38553657/

Publication of results

Partially published


Result

URL related to results and publications

https://pubmed.ncbi.nlm.nih.gov/38553657/

Number of participants that the trial has enrolled

846

Results

Bland-Altman analysis showed minimal fixed bias between iATT and MRI-PDFF with excellent reproducibility. The area under the curve to distinguish lipodystrophy grades 1, 2, and 3 was 0.887, 0.882, and 0.867, respectively. Skin to capsular distance greater than 25 mm was identified as the only significant factor causing discordance. no interaction between MRI-logPDFF and MRE-LSM on iATT values was observed.

Results date posted

2024 Year 04 Month 08 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Several preliminary reports have suggested the utility of ultrasound attenuation coefficient measurements based on B-mode ultrasound, such as iATT, for diagnosing steatotic liver disease. Nonetheless, evidence supporting such utility is lacking. This prospective study aimed to investigate whether iATT is highly concordant with magnetic resonance imaging (MRI)-based proton density fat fraction (MRI-PDFF) and could well distinguish between steatosis grades.

Participant flow

A cohort of 846 individuals underwent both iATT and MRI-PDFF assessments. Steatosis grade was defined as grade 0 with MRI-PDFF < 5.2%, grade 1 with 5.2% MRI-PDFF < 11.3%, grade 2 with 11.3% MRI-PDFF < 17.1%, and grade 3 with MRI-PDFF of 17.1%. The reproducibility of iATT and MRI-PDFF was evaluated using the Bland-Altman analysis and intraclass correlation coefficients, whereas the diagnostic performance of each steatosis grade was examined using receiver operating characteristic analysis.

Adverse events

None

Outcome measures

Compared to MRI-PDFF, iATT showed excellent diagnostic accuracy in grading steatosis. iATT could be used as a diagnostic tool instead of MRI in clinical practice and trials. Trial registration This study was registered in the UMIN Clinical Trials Registry (UMIN000047411).

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 04 Month 08 Day

Date of IRB

2021 Year 04 Month 23 Day

Anticipated trial start date

2021 Year 05 Month 27 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 03 Month 31 Day

Date trial data considered complete

2023 Year 03 Month 31 Day

Date analysis concluded

2023 Year 03 Month 31 Day


Other

Other related information

None


Management information

Registered date

2022 Year 04 Month 06 Day

Last modified on

2024 Year 04 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054070


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name